Abstract:Abstract Background Obstructive sleep apnea (OSA) is currently recognized as a risk factor for dysmetabolism. However, the effect of OSA on serum uric acid (SUA) levels in patients with obesity remains unclear. This study aimed to investigate the association between SUA and OSA in patients with obesity and to determine whether bariatric surgery (laparoscopic sleeve gastrectomy (LSG)) could decrease SUA levels. Methods A total of 182 patients with obesity and OSA were recruited for this study. All patients' demographic data, polysomnography (PSG), SUA, blood glucose, lipids, and glycosylated hemoglobinA1c (HbA1c) were recorded. The patients were divided into non-hyperuricemia-OSA (NHUA-OSA, ≤ 360 µmol/L) and hyperuricemia-OSA (> 360 µmol/L) groups according to their SUA levels, and the differences between the two groups were compared and analyzed. Multiple logistic regression analysis was performed to identify the independent risk factors for hyperuricemia in obese subjects with OSA. At follow-up, changes in BMI and SUA levels before and after bariatric surgery were statistically analyzed using repeated measures analysis of variance (ANOVA). Results Hyperuricemia was present in 76.9% of the patients with obesity and OSA. Body mass index (BMI), oxygen desaturation index (ODI), and time spent below 90% oxygen saturation (T90%) were higher, and rapid eye movement (REM) duration during sleep and mean oxygen saturation (meanSpO 2 ) were lower in the HUA-OSA group than in the NHUA-OSA group (all P < 0.05). Multiple logistic regression analysis showed that BMI was an independent risk factor for hyperuricemia in patients with obesity and OSA (OR 1.103, 95% CI1.032–1.178, P = 0.004) after adjusting for confounding factors. Receiver operating characteristic (ROC) curve analysis revealed that the area under the curve (AUC) for BMI was 0.695 and the optimal cutoff value was 41.80kg/m 2 . The BMI and prevalence of hyperuricemia gradually decreased in 23 patients reassessed at the 1, 3, and 6 months follow-ups after bariatric surgery (all P < 0.05), while the SUA level increased at 1 month and started to decrease only at 3 months after the surgery ( P < 0.05). Conclusion BMI is a useful screening tool for detecting hyperuricemia in patients with obesity and OSA. Our results also demonstrated that bariatric surgery can effectively decrease SUA levels.

Serum Uric Acid Is Independently Associated with Risk of Obstructive Sleep Apnea-Hypopnea Syndrome in Chinese Patients with Type 2 Diabetes

Association of Serum Uric Acid and Cardiovascular Events in Patients with Obstructive Sleep Apnea

The Relationship of Serum 25-Hydroxyvitamin-D Level with Severity of Obstructive Sleep Apnea in Patients with Type 2 Diabetes Mellitus

Association of serum uric acid with all-cause and cardiovascular mortality in obstructive sleep apnea

The relationship between obstructive sleep apnea-hypopnea syndrome and blood uric acid levels

Serum Uric Acid Levels Are Associated with Hypertension and Metabolic Syndrome but Not Atherosclerosis in Chinese Inpatients with Type 2 Diabetes.

Influnce of Obstructive Sleep Apnea Hypopnea Syndrome to the Levels of Serum Uric Acid and Blood Lipid

The Relationship Between Obstructive Sleep Apnea Hypopnea Syndrome and Renal Function in Patients with Type 2 Diabetes Mellitus

Obstructive Sleep Apnea is Associated with Impaired Glucose Metabolism in Han Chinese Subjects.

Influence of Obstructive Sleep Apnea Syndrome on Blood Glucose Control and Occurrence of Chronic Diabetic Complications in Type 2 Diabetes Patients

The Prevalence and Characteristics of Obstructive Sleep Apnea in Hospitalized Patients with Type 2 Diabetes in China

Serum advanced glycation end products are associated with insulin resistance in male nondiabetic patients with obstructive sleep apnea

Serum Adiponectin Levels in Adult Male Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Correlation between OSAHS and Early Peripheral Atherosclerosis Indices in Patients with Type 2 Diabetes Mellitus in China: A Cross-Sectional Inpatient Study

Association of Diabetic Microvascular Complications and Parameters of Obstructive Sleep Apnea in Patients with Type 2 Diabetes

[Serum Γ-Glutamyltransferase in Obstructive Sleep Apnea Hypopnea Syndrome and Its Role in Predicting Concomitant Diabetes Mellitus].

Prevalence of obstructive sleep apnea syndrome in hospitalized patients with type 2 diabetes in Beijing, China

Obstructive sleep apnea hypopnea syndrome in patients with type 2 diabetes mellitus and its relationship with neurotransmitter levels in cerebral tissue

Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes

Higher body mass index is associated with higher hyperurcemia in patients with obesity and obstructive sleep apnea

Serum uric acid is related to left ventricular geometry and function in patients with obstructive sleep apnea